|
N.A. Chernikova 1, A.S. Ametov 1, M.B. Antsiferov 2
BASAL INSULIN THERAPY: EXPERIENCE IN CLINICAL PRACTICE
|
№16 / 2013
|
|
E.A. Ushkalova
NEW CLASS OF ANTIDIABETIC DRUGS - SODIUM- GLUCOSE COTRANSPORTER INHIBITORS
|
№16 / 2013
|
|
N.A. Chernikova 1, M.B. Antsiferov 2
ROLE AND PLACE OF HYPOGLYCEMIA IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
|
№16 / 2013
|
|
E.V. Biryukova, T.B. Danilova
EFFICACY AND SAFETY OF GLYCAEMIC CONTROL USING DIABETON MR: PREREQUISITE FOR SUCCESSFUL PREVENTION OF CHRONIC COMPLICATIONS OF TYPE 2 DIABETES MELLITUS
|
№16 / 2013
|
|
I.Yu.Demidova, V. V. Boeva
EARLY DIAGNOSIS AND TREATMENT OF IMPAIRED FASTING GLUCOSE REDUCES RATE OF ITS CONVERSION TO IMPAIRED GLUCOSE TOLERANCE AND TYPE 2 DIABETES MELLITUS
|
№10 / 2013
|
|
I.Yu.Demidova
The Clinical Advantages Of The First Human Glp-1 Analogue Liraglutide In The Treatment Of Patients With Type 2 Diabetes Mellitus
|
№5 / 2013
|
|
N.A. Petunina, L.V. Trukhina, E.I. Sinitsina, M.B. Antsiferov
Benefits Of Long-acting Metformin
|
№5 / 2013
|
|
A.S.Ametov
Type 2 Diabetes Mellitus And Non-alcoholic Fatty Liver Disease: Guidelines For Endocrinologists
|
№5 / 2013
|
|
E.E.Arinina, M.A.Rasheed, M. B. Antsiferov
Pharmacoeconomic Analysis Of Advantages Of Combined Incretin Therapy In Patients With Type 2 Diabetes Mellitus By The Example Of Vildagliptin
|
№5 / 2013
|
|
A.F.Verbovoy, L.A.Sharonova, N.I.Verbovaya, D. V. Demidova, A.V.Kapishnikov
The Levels Of Vitamin D3 And Parameters Of Bone Metabolism In Women With Type 2 Diabetes Mellitus
|
№5 / 2013
|
|
M. B. Antsiferov, G. Schernthaner, A.S.Ametov
Innovative Hypoglycemic Therapy: A New Strategy For An Old Problem
|
№5 / 2013
|
|
L.A.Ruyatkina, A.V.Lomova, D. S. Ruyatkin
Bone Status In Type 2 Diabetes Mellitus
|
№5 / 2013
|
Русский
